Washington, United States,
08048034981

OBESITY/WEIGHT MANAGEMENT · Semaglutide 1.7 mg

Obesema 1.7 mg injection

In stock

Description

Obesema 1.7 mg injection (by Alkem) is a weekly GLP-1 receptor agonist primarily used for chronic weight management and type 2 diabetes, acting as a sub-cutaneous injection. Key tags include: Semaglutide, obesity medication, weekly weight loss pen, type 2 diabetes management, and chronic weight management

Specifications

Active Ingredients Semaglutide 1.7 mg
Storage Requirement 2–8°C
Category GLP-1 receptor agonist